Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Eidos Therapeutics Inc (EIDX)

Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It discovers and develops novel oral therapy for the treatment of diseases caused by transthyretin amyloidosis. Eidos Therapeutics, Inc. is based in San Francisco, United States.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Sep, 2017
Sales 26,690 0 0 0 -6,830
Sales Growth unch unch unch +100.00% -68.64%
Net Income -37,840 -33,290 -11,940 -2,540 13,000
Net Income Growth -13.67% -178.81% -370.08% -119.54% +224.19%

Balance Sheet

(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Sep, 2017
Total Assets 203,820 160,110 6,340 1,970 6,840
Total Assets Growth +27.30% +2,425.39% +221.83% -71.20% +920.89%
Total Liabilities 32,390 5,110 2,510 650 0
Total Liabilities Growth +533.86% +103.59% +286.15% unch unch

Cash Flow

(Values in U.S. Thousands) Dec, 2019 Dec, 2018 Dec, 2017 Dec, 2016 Sep, 2017
Operating Cash Flow -31,650 -33,140 -9,720 -2,050 -6,150
Operating Cash Flow Growth +4.50% -240.95% -374.15% +66.67% -84.68%
Net Cash Flow 34,010 151,650 3,540 1,930 6,840
Change in Net Cash Flow -77.57% +4,183.90% +83.42% -71.78% +920.89%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot